85 results
Page 2 of 5
8-K
EX-10.1
c9y654
4 Nov 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
jzfz01eqn
27 Jul 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
kve9rx1bqu ycikn
2 Nov 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
eluylbg py2josexwomx
21 Aug 07
Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase Iii Clinical Trial for Lead Aversion® Technology Product Candidate
12:00am
8-K
EX-10.1
yfqs9t i63zcwfynqln
31 Jan 06
Acura Pharmaceuticals, Inc. Secures Bridge Funding
12:00am
8-K
EX-10.5
ktj0ay16s 3a71cryu
31 Jan 06
Acura Pharmaceuticals, Inc. Secures Bridge Funding
12:00am
8-K
EX-10.2
arxelg59gjw
10 Nov 05
Acura Pharmaceuticals, Inc. Reports Financial Results
12:00am
8-K
EX-10.7
nqicq2b
10 Nov 05
Acura Pharmaceuticals, Inc. Reports Financial Results
12:00am
8-K
EX-10.6
bznur1guf75f4 p7
10 Nov 05
Acura Pharmaceuticals, Inc. Reports Financial Results
12:00am
8-K
EX-10.6
tm7tz9 dmb8gl3jc
16 Sep 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.5
q842282f0 ng7bv
16 Sep 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
kyc5615
16 Sep 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
oin4umctdhgc
23 Jun 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.6
se9v1
23 Jun 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.5
j2t 804smjk
23 Jun 05
Entry into a Material Definitive Agreement
12:00am